VEGFi
1 abstract
Abstract
Adverse events (AEs) of immune checkpoint therapy (ICT) combined with vascular endothelial growth factor inhibitors (VEGFi) vs. ICT alone: A pooled meta-analysis of 1735 patients.Org: UPMC Harrisburg, MD Anderson Cancer Center, University of Texas Health Science Center at San Antonio, University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX,